320 related articles for article (PubMed ID: 38308498)
21. Application of circulating tumor DNA in breast cancer.
Zhao Y; Sheng M; Zheng L; Xiong D; Yang K; Luo Y
Breast J; 2020 Sep; 26(9):1797-1800. PubMed ID: 32052544
[TBL] [Abstract][Full Text] [Related]
22. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
Fontanilles M; Duran-Peña A; Idbaih A
Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
24. Role of liquid biopsies in colorectal cancer.
Wills B; Gorse E; Lee V
Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
[TBL] [Abstract][Full Text] [Related]
25. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Rossi G; Ignatiadis M
Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
[TBL] [Abstract][Full Text] [Related]
26. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
27. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
Junqueira-Neto S; Batista IA; Costa JL; Melo SA
Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
[TBL] [Abstract][Full Text] [Related]
28. Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review.
Krebs MG; Malapelle U; André F; Paz-Ares L; Schuler M; Thomas DM; Vainer G; Yoshino T; Rolfo C
JAMA Oncol; 2022 Dec; 8(12):1830-1839. PubMed ID: 36264554
[TBL] [Abstract][Full Text] [Related]
29. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
[TBL] [Abstract][Full Text] [Related]
30. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
[TBL] [Abstract][Full Text] [Related]
31. Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.
Weng J; Atyah M; Zhou C; Ren N
Clin Exp Med; 2020 Aug; 20(3):329-337. PubMed ID: 32239299
[TBL] [Abstract][Full Text] [Related]
32. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
Theil G; Fornara P
Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy in CNS tumors: Current status & future perspectives.
Husain N; Husain A; Mishra S; Srivastava P
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
[TBL] [Abstract][Full Text] [Related]
34. Circulating tumor cells in precision medicine: challenges and opportunities.
Rupp B; Ball H; Wuchu F; Nagrath D; Nagrath S
Trends Pharmacol Sci; 2022 May; 43(5):378-391. PubMed ID: 35272862
[TBL] [Abstract][Full Text] [Related]
35. Advanced liquid biopsy technologies for circulating biomarker detection.
Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
[TBL] [Abstract][Full Text] [Related]
36. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
Mohanty A; Mohanty SK; Rout S; Pani C
Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
[TBL] [Abstract][Full Text] [Related]
37. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.
Lone SN; Nisar S; Masoodi T; Singh M; Rizwan A; Hashem S; El-Rifai W; Bedognetti D; Batra SK; Haris M; Bhat AA; Macha MA
Mol Cancer; 2022 Mar; 21(1):79. PubMed ID: 35303879
[TBL] [Abstract][Full Text] [Related]
38. Liquid biopsy for brain tumors.
Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
[TBL] [Abstract][Full Text] [Related]
39. Liquid Biopsy Based on Circulating Cancer-Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine.
Jiménez-Zenteno AK; Cerf A
Adv Biosyst; 2020 Feb; 4(2):e1900164. PubMed ID: 32293131
[TBL] [Abstract][Full Text] [Related]
40. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance.
Kilgour E; Rothwell DG; Brady G; Dive C
Cancer Cell; 2020 Apr; 37(4):485-495. PubMed ID: 32289272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
